Business
Bio Spectrum
Kashiv BioSciences secures Rs 648 Cr financing from UBI
Kashiv BioSciences, a biopharmaceutical company, has secured financing of Rs 648 crore from the Union Bank of India.
1 min |
February 2026
Bio Spectrum
BioVaram to establish Centre for Excellence in Life Sciences in Hyderabad
In a path-breaking move, marking a significant leap in India's journey toward becoming a global innovation hub in line with Vision 2047, BioVaram (UR Advanced Therapeutics), a rapidly growing biotech startup incubated at ASPIRE-BiONEST, University of Hyderabad, has announced the establishment of a landmark Centre for Excellence in Life Sciences focusing on Tissue Engineering, Regenerative Medicine, and Cell and Gene Therapy.
1 min |
February 2026
Bio Spectrum
Senores Pharmaceuticals makes Rs 91 Cr acquisition of Apnar Pharma
Senores Pharmaceuticals has entered into a definitive agreement to acquire 100 per cent equity stake in Apnar Pharma, along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets.
1 min |
February 2026
Bio Spectrum
Revvity introduces AI-augmented design platform for molecular and materials discovery
US-based Revvity, Inc. has announced the introduction of its forthcoming Signals Xynthetica Models-as-a Service (MaaS) AI offering within the Revvity Signals platform.
1 min |
February 2026
Bio Spectrum
Intas Pharmaceuticals collaborates with IntegriMedical
Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India's first NeedleFree Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynaecology treatments across India. This marks a significant milestone in IVF and women's health.
1 min |
February 2026
Bio Spectrum
Beckman Coulter Life Sciences introduces Biomek i3 Benchtop Liquid Handler
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, makes liquid handling research more accessible with the launch of the Biomek i3 Benchtop Liquid Handler. Purpose-built for low- to medium-throughput workflows, the Biomek i3 Benchtop Liquid Handler delivers powerful automation in a compact, cost-effective format.
1 min |
February 2026
Bio Spectrum
PAHO explores role of primary healthcare in addressing NCDs
The Pan American Journal of Public Health, the scientific publication of the Pan American Health Organization (PAHO), recently published a special issue dedicated to strengthening primary healthcare to address noncommunicable diseases (NCDs) in the Americas.
1 min |
February 2026
Bio Spectrum
API Holdings names Shashi Tiwari as CHRO
API Holdings, India's largest digital healthcare platform, has appointed Shashi Tiwari as its Chief Human Resource Officer (CHRO), further strengthening its leadership team as the group continues to scale its healthcare businesses.
1 min |
February 2026
Bio Spectrum
BIRAC inks Letter of Intent with Global Antibiotic Research & Development Partnership
Biotechnology Industry Research Assistance Council (BIRAC), under the Department of Biotechnology (DBT), Government of India, has announced a Letter of Intent (LOI) with the Global Antibiotic Research & Development Partnership (GARDP), a Swiss not-for-profit organisation that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health.
1 min |
February 2026
Bio Spectrum
Biocon signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries
Bengaluru-based Biocon Limited has announced the signing of an out-licensing agreement with Mumbai-based Ajanta Pharma Ltd, a specialty pharmaceutical formulations company, to market its vertically integrated drug product, Semaglutide, used to improve glycemic control in adults with type-2 diabetes.
1 min |
February 2026
Bio Spectrum
JNCASR & CrisprBits to open CRISPR Centre of Excellence in Innovation & Translation
A Letter of Intent (LOI) has been signed for the establishment of CRISPR Centre of Excellence for Innovation and Translation (CoE-CIT).
1 min |
February 2026
Bio Spectrum
WHO prequalifies first two rapid antigen detection tests for COVID-19
The World Health Organization (WHO) has announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for SARS-COV-2, the virus that causes COVID-19.
1 min |
February 2026
Bio Spectrum
PlasmaGen Biosciences raises Rs 150 Cr marking strong growth trajectory
PlasmaGen Biosciences, a leading biopharmaceutical company focused on blood plasma-derived therapeutics, has raised Rs 150 crore in a minority equity financing round at an Rs 1500+ crore valuation.
1 min |
February 2026
Bio Spectrum
Pinnacle Blooms Network to scale AI-powered child development operating system with $70 M funding
A leading global healthcare investment fund has offered $70 million to Pinnacle Blooms Network, the flagship paediatric-therapy enterprise of Hyderabad-based startup Bharath Healthcare Laboratories.
1 min |
February 2026
Bio Spectrum
Motilal Oswal Alternates invests $72 M in Sensa Core Medical Instrumentation
Motilal Oswal Alternates has announced a significant minority investment of $72 million in Sensa Core, an innovation driven medical devices' company focused on advancing healthcare technology in India. Founded in Hyderabad in 2006, Sensa Core is engaged in design (IP-driven), development, manufacturing and distribution of specialised in-vitro diagnostic devices.
1 min |
February 2026
Bio Spectrum
Labour codes: Standardising compliance for life sciences sector
The Government has consolidated 29 labour laws into four comprehensive Labour Codes. This move for across sectors is being seen as labour-friendly; however, a certain section of society seems to be wary. Experts from the life sciences sector welcome the new move on one hand, but express concern about the likely challenges.
4 min |
February 2026
Bio Spectrum
ErlySign to launch oral cancer detection kit by April 2026
ErlySign, a Nagpur-based biotech startup developing India’s first salivary biomarker-based screening test for early-stage oral cancer, has announced the successful completion of its large-scale clinical trial conducted across 1,000 patients.
1 min |
February 2026
Bio Spectrum
An affordable diagnostic kit can be a profitable business in India, but profitability and impact must go hand in hand”
Cervical Cancer is the second leading cause of cancer deaths in India with more than 80,000 women losing their lives every year to the disease despite it being curable, if detected in early stages. Started in 2020, Pragmatech Healthcare Solutions, a biotech startup from Vadodara, launched CERVICHECK, India's first CDSCO approved at-home, self-sampling kit for HPV (Human Papillomavirus) screening to bring Cervical Cancer Screening to every woman across the country. Recently it received the Infosys Foundation Aarohan Social Innovations Award under the Jury's Special Awards category. In an interview with BioSpectrum India Anirban Palit, Managing Director and Co-founder, Pragmatech shared his thoughts about the award and his plan and business model for the company. Edited excerpts;
4 min |
February 2026
Bio Spectrum
Saving Lives with BSL-4 Labs
Starting a new era of India's health security, a biosafety level 4 (BSL-4) lab is being built at the cost of Rs 362 crore at Gujarat Biotechnology Research Centre in Gandhinagar. Although this will be India's second high-level lab after the National Institute of Virology in Pune (established in 2012), this is the first lab being built by a state government, with an area of 11,000 square metres. Back in 2024, the Defence Research and Development Organisation (DRDO) took a significant step in enhancing India's chemical-biological defence capabilities with the inauguration of a BSL-4 laboratory at the Defence Research and Development Establishment (DRDE) in Gwalior.
2 min |
February 2026
Bio Spectrum
Africa advances health system responsiveness and epidemic preparedness
The Africa Centres for Disease Control and Prevention (Africa CDC) and Zipline International, Inc. have signed a Memorandum of Understanding (MoU) to improve health outcomes and expand economic opportunities across Africa through drone-enabled health logistics.
1 min |
February 2026
Bio Spectrum
Health Minister Nadda releases 10th edition of Indian Pharmacopoeia
Union Minister for Health and Family Welfare and Chemicals and Fertilizers, J P Nadda released the Indian Pharmacopoeia 2026 (IP) 2026the 10th edition of the Official Book of Drug Standards of India at Dr. Ambedkar International Centre in New Delhi recently.
1 min |
February 2026
Bio Spectrum
“India has strong medical talent, increasing health awareness, and a real need for structured preventive care”
Preventive healthcare has long been an integral part of Japan's medical system, where annual health checkups are mandatory and early detection is key to improving population health outcomes. Launched in Bengaluru in 2021, NURA—India's first AI-powered preventive health screening centre—is a collaboration between Fujifilm's advanced imaging technology and Dr Kutty's Healthcare's clinical expertise. Designed to deliver comprehensive screenings in under 120 minutes with same-day reporting, NURA brings Japan's preventive care ethos to India. In an interview with BioSpectrum, Masaharu Morita, Founder & Program Director, NURA, reflects on his five-year journey and the evolving role of AI-led preventive healthcare in India. Edited excerpts;
4 min |
February 2026
Bio Spectrum
AI fuels new era of cancer detection
As the world stands at the cusp of the Artificial Intelligence (AI) revolution, the Indian government has established regulatory guidelines for AI driven cancer detection and diagnostic software, categorising it alongside medical devices. These new regulations will require Al-based cancer detection tools, currently in use at various hospitals and diagnostic centres, to secure regulatory approval before widespread deployment. Simultaneously, India is experiencing a surge in startups offering Al-driven cancer screening solutions, often touting early-detection capabilities. Let's find out how these new regulatory developments can foster innovations to combat cancer in the long run.
6 min |
February 2026
Bio Spectrum
"Without intervention, heat stress will continue to erode productivity, income and worker health at a national scale"
Founded in 2024 in Chennai, Sukoontech Solutions Private Limited, by Phalgun Vyas, is redefining wearable comfort through customised, temperature-regulating clothing. Addressing the serious challenge of occupational heat stress that affects workforce health and productivity across industries, Sukoon is pioneering smart solutions for extreme environments. Its innovative cooling wearables, including a smart jacket powered by a Digital Hybrid-IDEC mechanism, enhance safety and performance in high-heat conditions. Recently, it received the Infosys Foundation Aarohan Social Innovations Award under the Jury's Special Awards category. In an interview with BioSpectrum India Phalgun Vyas, Founder & CEO, Sukoontech Solutions shared his vision and journey. Edited excerpts;
4 min |
February 2026
Bio Spectrum
Simple, frequent and non-negotiable monitoring alone can prevent a significant share of waterborne disease
CLUIX Private Limited, a New Delhi-based deep-tech cleantech startup, is redefining water quality monitoring through its AI- and IoT-enabled solutions that ensure safe and accessible water for communities and industries alike. Recently, CLUIX received the Infosys Foundation Aarohan Social Innovations Award, recognising its impactful innovation in the water and sustainability space. In an interview with BioSpectrum India Chitranjan Singh, Founder & Chairman of CLUIX, shared his entrepreneurial journey, leadership vision, and the mission driving this nationally acclaimed innovation. Edited excerpts;
4 min |
February 2026
Bio Spectrum
Uncompromising on Quality: Schedule M Hits Small Pharma
The implementation of the revised Schedule M standards marks a defining moment for India's pharmaceutical industry. Intended to align domestic manufacturing with global Good Manufacturing Practices (GMPs), Schedule M under the Drugs and Cosmetics Rules, 1945, seeks to strengthen quality assurance, enhance patient safety, and bolster India's international credibility.
2 min |
February 2026
Bio Spectrum
'Biosimilars in India are typically priced 60-80 per cent lower than originator biologics, significantly improving access for patients and public health programmes'
Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, shares insights on India's rapidly maturing biosimilars landscape, the shift from import dependence to export leadership, and the road ahead. Edited excerpts:
3 min |
February 2026
Bio Spectrum
Strong follow-on funding shows growing maturity of TechBio
India is emerging as a powerful hub for deep science and biotechnology, driven by favourable geopolitics, a large domestic market, strong pharmaceutical and chemicals infrastructure, and supportive government policies. With initiatives such as the $12 billion Research, Development and Innovation (RDI) Fund, the BioE3 policy, and regulatory support for advanced genetic technologies, the country is positioning itself for rapid innovation-led growth. A growing talent pool, returning global expertise, expanding pharma GCCs, and capital-efficient manufacturing further strengthen India's advantage. Together, these factors create a strong foundation for globally competitive, sustainable science-driven enterprises.
4 min |
February 2026
Bio Spectrum
Building Breakthrough Medical Devices
Dr Ria Khurana founded RNT Health Insights, a Chandigarh-based healthtech startup specialising in Al-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, in 2022 along with Dr Tanmaya Gulati.
2 min |
January 2026
Bio Spectrum
Bridging classical epidemiology with modern science
A physician scientist with a MBBS from Lady Hardinge Medical College, (University of Delhi), a post-graduation in Paediatrics and a PhD from All India Institute of Medical Sciences (AIIMS), New Delhi, Prof.Shinjini Bhatnagar served as Professor of Eminence at Translational Health Science and Technology Institute (THSTI) until February 2023 and was subsequently appointed Distinguished Professor at THSTI until May 2025.
2 min |